• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About
  • Contact

Daily Business Magazine

A magazine complement to the Daily Business website



  • Life, Arts & Leisure
    • Creative
    • Festival
      • Festival Reviews
    • Film
    • Food & Drink
    • Stage Shows
    • Life
    • Leisure
      • Rio Recommends – dog walks and cafes
    • Homes
    • Style
    • Travel
  • Analysis & Opinion
    • Bill Magee
    • Craig Alexander Rattray
    • Karen Harvie
    • Keith Anderson
    • Russell Dalgleish
    • Terry Murden
    • Viewpoint
  • Interviews
  • Notebook
  • Working Life
    • Careers & Management
    • Finance and legal
    • Technology
      • Tech Talk
    • Well Being
  • Daily Business News
    • All Content
Home » All Content » Interviews » Interview: Jim Mellon, global investor

Interview: Jim Mellon, global investor

August 24, 2017 by Terry Murden Leave a Comment

Jim Mellon
Jim Mellon: fascination with long life (photo by Terry Murden)

It’s life, Jim, but not as we know it

Jim Mellon is 60. He doesn’t want anyone to know that, so just keep it between you and me, okay? What’s interesting, though, is that he could be just half way through his life, if current predictions are anything to go by.

Mellon is a rich man. Worth about £850 million. He’s up there as one of the wealthiest Scots on the planet. But, as everyone knows, you can’t take your money with you, so best to enjoy it while you can.

In Mellon’s case it’s about investing in his fascination with long life. He’s co-authored a book on the subject and tours the world talking to scientists and anyone who has a theory on the elixir of youth.

“Within 20 years life expectancy will rise to 110 or 120,” he says. “It is equivalent to living another 50% of your life.  It will be like going from a 24 hour day to 36 hours.”

Edinburgh-born Mellon made his money on the markets and is a long time pal of Linlithgow-based financial adviser Alan Steel who invited him to speak at at an event at the Waldorf Astoria (still better known as the Caley) hotel in the city.

Mellon may be one of the world’s mega-rich, with homes dotted around some famous playgrounds, but there are some things that keep him grounded. Last time he was back home to speak it was at the New Club which has a strict rule on ties. So before his speech he dashes up the road to buy a tie, except it doesn’t really matter this time. The Caley is relaxed about ties.

He re-appears, clad in tartan neckwear, and takes to the lectern to deliver a Powerpoint display on his view of stock markets, President Trump and scientific developments in making us all live longer.

This is not so much an interview as a few snatches of conversation after his presentation. He expresses surprise that he seemed pessimistic despite the first half of his slide show suggesting markets were over-valued and that Trump’s hopes of 4% growth in the US economy was an “impossible” target.

“I thought I was being quite positive,” says Mellon, and he was probably correct in respect of the second half when he spoke enthusiastically about investment opportunities in anything connected with extending life expectancy.

The point of this is that he believes it is no longer a vision of the future.

“It is happening now,” he says, pointing out that the number of centenarians will soon become “a trivial event”.

He notes that the first telegrams to 100-year-olds were sent by the King in 1917 to 24 people. By 2040 there will be 60,000.

“Life expectancy in 1900 was 31. In 2015 it was 72. By 2030 it could be 120. Just look at the charts.”

Mellon has taken all this on board to colour his investment strategy. He is still mainly in property – mostly in Berlin – but has about 10% in “risk” businesses, mainly life sciences which have evolved from the development stage to producing results.

He talks confidently of cures for cancer, or at least drugs that keep it under control, and for heart disease and even dementia.

All these offer investment opportunities and already he is expecting to exit one life science company with a 40 times return which will net him about £30m.

He certainly seems to have more confidence in these businesses than in the American economy under President Trump whom he says has achieved “nothing at all”.

He is worried about the rise of the markets and believes some of the more popular stocks are hugely over-valued: Tesla at $800,000 per car against BMW at $25,000 and General Motors at $5,000.

His forecast? “A good chance of a 15% to 20% correction in major world markets in the next two years.”

He believes Brexit is a sideshow in Europe to the bigger issues such as the survival of the euro. Mellon is convinced that two or three countries will withdraw, with Italy topping his list of likely drop-outs. Britain, he says, will probably adopt a Norwegian model in Europe.

The last word is on former First Minister Alex Salmond whom he met at the Fringe.

“I spent the afternoon with him,” he says. “I would not have voted for independence and I’m not convinced it will happen, but then again I don’t think he is either.”

PERSONAL CHECKLIST

Birthplace: Edinburgh

Age: 60

Education:  Oxford University (Master’s degree in Politics, Philosophy and Economics)

Career highlights: Made “spectacular” amounts of money in Russia’s transition to a market economy in the 1990s. Founded the fund management firm Charlemagne Capital in the 1990s. He is chairman of Burnbrae.

Home: Domiciled in the Isle of Man but has numerous homes around the world, including San Francisco and Ibiza.

Not very keen on the EU?

Donated at least £100,000 towards campaigns to leave the EU in 2015

 

 

Share this:

  • Post

Like this:

Like Loading...

Related

Filed Under: Interviews, Terry Murden, Working Life Tagged With: Jim Mellon

hello

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar




Editor’s Pick

Ian Ritchie

Benefits flow from a joined up nation

Ian Ritchie

… [More...] about Benefits flow from a joined up nation

Mary Ann Smith (DB Media Services)

Interview: Mary Ann Smith, coach and CEO

Terry Murden

… [More...] about Interview: Mary Ann Smith, coach and CEO

Terry Murden

Time for PM to be pragmatic on North Sea

Terry Murden

… [More...] about Time for PM to be pragmatic on North Sea

Karen Harvie of Aberdein Considine

Harassment changes: all you need to know

Karen Harvie

… [More...] about Harassment changes: all you need to know

Advertising



Footer

  • All Content
  • Site Map
  • Privacy Policy
  • Facebook
  • X
  • Instagram
  • LinkedIn
  • WordPress

Copyright © 2026 · Design by jPAD Consulting · Magazine Pro · Genesis Framework

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT
 

Loading Comments...
 

    %d